INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDY

Challenge/Study Title	Protocol Steps – Count
Challenge Coach (The Person in Charge of This Research Study)	Reviewer User
Sponsor	This study is made possible by your payment to join.
Challenge Cost	$20
Included Products & Services
Outcome Measures
Contact	help@efforia.com

Introduction to the Study

Welcome to this unique opportunity to participate in a research study on the Efforia platform. Your involvement and support make this research possible. We invite you to carefully review this document, which aims to provide you with comprehensive information to help you make an informed decision about your participation. Please ensure all your questions are answered to your satisfaction before proceeding.

Efforia is a citizen science platform. This study, like many on Efforia, is effectively sponsored by participants. This approach is unique because it requires a small payment. This makes the study possible when traditional research funding is limited or unavailable. Your payment covers all the supplies, services, information, and tools you need to participate.

While you could buy these products and services separately on the open market for a similar total cost, Efforia bundles them into one purchase for ease. Efforia also organizes these items and provides instructions to help create a thorough, data-driven research experience – something that would otherwise be difficult to do. This setup not only allows you to track and understand the impact on your own life, making it easier to make informed personal health decisions, but it also helps advance broader research findings. These findings can benefit others who might not be able to afford self-experimentation purchases without a strong guarantee of results.

What’s Involved

Responsibilities and Timeline in the Study:

As a participant in this clinical study, your adherence to the prescribed schedule and treatment activities is crucial. Below is a detailed outline of your responsibilities, the overall schedule, and the treatment activities, along with the frequency of these activities and subsequent measurements.

Overall Schedule and Specific Timeline:

1. Initial Consultation and Baseline Measurements: This will occur on your first visit to the study center. It involves an in-depth health assessment and baseline data collection.
2. Treatment Commencement: Following your initial assessment, treatment will begin as per the protocol specified for your group.
3. Regular Follow-up Visits: These visits will be scheduled at consistent intervals (e.g., weekly, biweekly, or monthly) to administer treatments and monitor progress.
4. Mid-study Assessment: At the midpoint of the study, a comprehensive evaluation will assess your response to the treatment.
5. Final Evaluation and Follow-Up: This will occur at the end of the treatment period and may involve a series of assessments to gauge long-term effects.

Detailed Description of Treatment Activities:

• Administration of Study Drug or Placebo: Depending on your group, you will receive either the study drug or a placebo at each treatment session.
• Behavioral or Physical Therapy Sessions: If applicable, these sessions will be conducted by qualified professionals aimed at complementing the primary treatment.

Frequency of Activities and Measurements:

• Treatment Sessions: Depending on the study phase, you might receive treatment daily, weekly, or biweekly.
• Assessment of Health Parameters: Vital signs and other health parameters will be checked during each visit.
• Regular Blood Tests and Imaging: Scheduled regularly to monitor your body’s response to the treatment.

Importance of Adhering to the Timeline:

• Participant Safety: Strict adherence to the timeline ensures that any potential adverse effects or complications are identified and managed promptly.
• Optimal Outcomes: Following the schedule allows the treatment to exert its intended effects, increasing the likelihood of a positive outcome for you.
• Scientific Validity: Your compliance affects the reliability of the data collected, impacting the study’s findings and potential future applications.

Adhering meticulously to the study schedule is essential not only for your safety and to maximize your individual outcomes but also to ensure the scientific integrity and success of the entire study. Your commitment is vital, and it is important that you attend all scheduled visits and adhere to all study protocols.

The Purpose of This Study

This study is designed to investigate [Specific Aim of the Study]. The results of this study could have significant implications for [General Field of Study], potentially improving [Expected Improvements]. This research is critical as it contributes to the broader scientific understanding of [Relevant Scientific Concepts].

Your Rights as a Participant

Ethical Considerations

Efforia upholds the same high ethical standards in research as seen in pharmaceutical and academic studies, despite only hosting and not sponsoring or conducting these studies. Your participation in this study is completely voluntary, and you are free to withdraw at any time without any adverse consequences.

Privacy and Confidentiality

Your personal information is protected through robust measures ensuring anonymity or confidentiality. All data processing by AI systems is designed to safeguard personal data against unauthorized access and misuse.

Respect and Personal Choice

All participants are treated with dignity and respect, acknowledging their autonomy and decision-making capabilities, particularly to join studies that might not otherwise be possible under a traditional funding model.

Maximized benefit and minimized risk

The design and execution of this study aim to maximize benefits and minimize harm to participants. This includes continuous monitoring for any adverse effects during participation.

Right to Your Own Results

Participants have the right to a complete explanation of the research once their involvement concludes, particularly if the study involves any form of deception.

Feedback Mechanism

A e-mail customer support process for providing immediate feedback or filing complaints regarding the study or its methodology and a promise that we will address and respond within 2 business days.

The Right to Leave a Study without Penalty at Any time

If you decide to withdraw from the study, you can do so at any time by visiting your Profile page, selecting “Your Protocols,” and clicking “Leave.” Upon leaving, you will be refunded for any consumable products that have not yet been shipped. For non-consumable products, a full refund will be issued upon their return in accordance with our return policy. This ensures that you can participate in the study with the assurance that your financial contributions are handled fairly and with respect for your consumer rights.

Risks and Benefits

Investigational New Drug Application Report

Product Name: Not Specified

Treatment: Not specified; placeholder text provided

Introduction and Summary of Known Risks

The following is a summary of known risks. However, research is limited, and there may be risks not covered by this document, risks that are currently unknown or unforeseen. Please consider these risks carefully, do your own research, and talk to a professional who knows you well and has expertise in this area, like your personal physician.

The safety profile of the product or treatment in question is not well-defined due to the absence of specific details regarding the nature of the treatment or its ingredients. As such, this report will outline general risks potentially associated with pharmaceutical treatments, based on common categories observed in clinical settings.

Serious Adverse Events (SAEs)

• Incidence of Cancer: Some pharmaceutical compounds can potentially increase the risk of cancer after long-term exposure. This is typically determined through extensive animal studies and long-term clinical trials.
• Exacerbation of Chronic Disease: Certain medications can exacerbate existing chronic conditions, depending on their mechanism of action and the patient’s health profile.
• Death and Life-Threatening Experiences: Although rare, death or life-threatening experiences can occur, particularly if there is an unexpected severe allergic reaction (anaphylaxis) or toxic reaction.
• Hospitalization (initial or prolonged): Adverse reactions may necessitate hospital admission, either for initial treatment or prolonged due to complications.
• Disability or Permanent Damage: Neurotoxicity, hepatotoxicity, or other organ damage can lead to long-term disability.
• Congenital Anomaly/Birth Defects: Some drugs are teratogenic and can lead to congenital anomalies if administered during pregnancy.
• Required Intervention: Some adverse effects might require medical or surgical intervention to prevent permanent impairment or damage.

Common Risk Categories

• Gastrointestinal Symptoms: Including nausea, vomiting, diarrhea, and constipation. These are often among the most common side effects but typically subside as the body adjusts to the medication.
• Skin & Hair Reactions: Rashes, itching, and hair loss can occur. These reactions are often documented in clinical trials and are usually reversible upon discontinuation of the drug.
• Headaches and Dizziness: Common with a wide range of medications and usually subside with continued use.
• Mood Changes and Mental Health Discomfort: Some medications can cause depression, anxiety, or other mood disturbances.
• Sleep Disturbances: Medications can affect sleep patterns, leading to insomnia or excessive sleepiness.
• Cognitive Impairment: Some treatments may cause temporary confusion, memory loss, or impaired cognitive function.

In the Case of an Adverse Event

Patients experiencing severe side effects should seek immediate medical attention. The limitations of Efforia in providing direct medical support should be clearly communicated to all patients, emphasizing the necessity of hospital or clinical intervention in severe cases.

Long-Term Dependence Issues

Long-term use of some pharmaceuticals can lead to dependence, both physical and psychological, necessitating careful management and possibly gradual tapering to discontinue.

Legality and Compliance

The use of any pharmaceutical treatment must adhere to regulations set by bodies such as the World Anti-Doping Association, National Collegiate Athletic Association, and corporate workplace standards. These institutions may have specific restrictions on the use of certain medications, affecting an individual’s eligibility for sports or employment.

Conclusion

Without specific details on the treatment or product, this report provides a generalized overview based on typical pharmaceutical risks. Each medication or treatment should be evaluated based on its specific clinical data, and this report should be adapted to include specific findings from preclinical and clinical evaluations of the product in question.

Frustration and irritation

Some users may experience discomfort, frustration, and irritation with the technology that Efforia uses to conduct studies, with the thoughts and feelings by answering probing questions and/or waiting for test results, and with a lack of progress towards reaching health goals.

No Benefit

A key risk to all studies is that there is no benefit, and that participants receive no benefit from the proposed intervention or treatment, despite the financial payment the participant has made.

Acknowledgment of Risk and Responsibility

There are some unique responsibilities for participants in citizen science trials, including some risks that participants should understand. Efforia does not endorse or sponsor this trial; it is simply hosted on the Efforia platform. This means that while Efforia provides the platform for the study, it does not influence the study’s design, conduct, or outcomes.

Consider your Own Risk-Benefit Comfort Level

Participants are encouraged to thoroughly weigh the risks and benefits of participation. “It is possible that not all risks and benefits are currently known. Participants have the responsibility to consult with their healthcare providers and conduct further research before enrolling in the study.”

Responsible for any Additional Costs & Medical Care

“In the case of an adverse event, it is the participant’s sole responsibility to seek and finance their medical treatment. Efforia, as a non-sponsor, is absolved from any claims and cannot reimburse any expenses incurred.”

Reporting Adverse Events

It is crucial for participants to report any adverse events to Efforia. This allows the sharing of such information with other participants, promoting overall safety and awareness within the community.

The Limits of Efforia Medical Oversight

If the study involves any lab tests or items requiring a prescription, asynchronous medical oversight will be available to assist in mitigating risks. However, participants should understand that this oversight does not replace personal responsibility or the need for local medical care.

Legal Acknowledgment

“This document serves as a legally binding acknowledgment of the risks associated with participating in a study and explicitly limits Efforia’s liability. Efforia will not be held liable for any claims except in cases of gross negligence or willful misconduct. This acknowledgment underscores the importance of personal diligence and responsibility throughout the study participation.”

Conflict of Interest Statement

As part of our commitment to ethical conduct and transparency in our citizen science clinical trial, it is essential to disclose the unique structure of our study. This clinical trial is hosted by Efforia, but it is uniquely sponsored by you, the participants. Efforia serves solely as the platform provider and does not sponsor or influence the study outcomes. Efforia takes a transaction fee on all the products and services included in this protocol. We have no financial or conflicts of interest otherwise. We are not paid by the sponsor of this study. To further reduce conflicts of interest, we will remind you once if you do not complete enrollment in this study. We will not remarket to you, or otherwise push you to join the study.

How we Reduce Conflicts of Interest:

It is crucial that participants do not have any financial relationship with the intervention methods or measurement providers used in the trial, nor should they be employees, investors, stakeholders, or protocol authors associated with these entities. Participation under such conflicts of interest could significantly compromise the study’s integrity and the validity of its results.

Consequences of Conflict of Interest Non-Compliance:

Should a participant fail to disclose such a conflict of interest or if a breach of this policy is discovered, the participant will be subject to immediate suspension from this platform. Depending on the nature of the violation, additional legal proceedings may be initiated as warranted by law to address the breach adequately.

“By joining this trial, you affirm that you understand the above conflict of interest restrictions and agree to comply fully with them. Your participation is valued, and your adherence to these guidelines ensures the validity and reliability of our collective scientific efforts.”

Data Protections

Data will be collected, used, and protected in compliance with data protection laws. Measures include encryption, access control, and anonymization techniques to ensure the security and confidentiality of your data.

California Experiential Research Subject’s Bill of Rights

Participants in California are entitled to certain rights under the California Experiential Research Subject’s Bill of Rights. For more information, please visit [Link to the policy].

Additional questions and closing

If you have questions, please contact help@efforia.com. It is up to you to do additional research and talk to your physician before joining a study. Your informed decision is crucial for your safety and the integrity of the research.

1. Authorization and Consent for Diagnostic Testing

1. I voluntarily consent and authorize CWI Physician Partners P.C., a California professional corporation; CWI Physician Partners P.C., a Hawaii professional corporation; CWI Physician Partners P.C., a Georgia professional corporation; CWI Physician Partners P.C., a Kansas professional corporation; CWI Physician Partners P.C., an Oregon professional corporation; CWI Physician Partners P.C., a Nevada professional corporation, CWI Physician Partners P.C., a Rhode Island professional corporation; CWI Physician Partners P.C., an Oklahoma professional corporation, as applicable (“CWI”) to review the collection, testing, and analysis for the purposes of a diagnostic screening test. I understand that there are risks and benefits associated with undergoing a diagnostic screening testing and there may be a potential for false positive or false negative test results. I assume complete and full responsibility to take appropriate action with regards to my test results. Should I have questions or concerns regarding my results, or a worsening of my condition, I shall promptly seek advice and treatment from an appropriate medical provider. I further acknowledge the following:
   1. I am the individual who will provide the sample for the Test(s) that I am requesting or I am the parent or legal guardian of a minor who is providing the sample for testing.
   2. I am at least eighteen (18) years of age or I am the parent or legal guardian of a minor who is providing the sample for testing.
   3. I have read and understand the information provided about the Test(s) that I have been provided on the website where I requested the Test.
   4. The information I have provided in connection with my request to CWI is correct to the best of my knowledge. I will not hold CWI or its employees or agents responsible for any errors or omissions that I may have made in providing such information.
   5. My health information and results may be shared with CWI employees and agents for the purpose of ordering, processing, and reporting my results.
   6. Medical Services provided by CWI are purely for diagnostic assistance purposes and do not create a physician-patient relationship, and do not constitute medical care or diagnosis or treatment of any condition, disease, or illness.
   7. I authorize CWI to contact me via text message to communicate with me regarding my test.

1. Patient Rights and Privacy Practices
   1. Notice of Privacy Practices and Patient Rights: CWI Notice of Privacy Practices describes how it may use and disclose your protected health information for other purposes that are permitted or required by law. To review a copy of CWI Notice of Privacy Practices, go to http://www.CynergyWellness.com.
   2. Disclosure to Government Authorities: I acknowledge and agree that my test results and associated information may be disclosed to appropriate county, state, federal, or other governmental and regulatory entities as may be permitted by law.

1. Release
   1. To the fullest extent permitted by law, I hereby release, discharge and hold harmless, CWI, including, without limitation, any its respective officers, directors, employees, representatives and agents from any and all claims, liability, and damages, of whatever kind or nature, arising out of or in connection with any act or omission relating to my diagnostic test or the disclosure of my test results.
   2. By selecting the ACKNOWLEDGEMENT during the registration process for diagnostic testing, I acknowledge and agree that I have read, understand, and agreed to the statements contained within this form. I have read the contents of this form in its entirety and voluntarily consent to proceed with these procedures.